Citations

Citations to this article as recorded by  

• The potential for medical therapies to address fistulizing Crohn’s disease: a state-of-the-art review
  Mohammad Shehab, Davide De Marco, Peter L. Lakatos, Talat Bessissow
  Expert Opinion on Biological Therapy.2024; 24(8): 733.     CrossRef

Citations

Citations to this article as recorded by  

• Smoking Experience before Adulthood Is Associated with an Increased Risk of Developing Ulcerative Colitis in Adult Ex-Smokers
  Yu Kyung Jun, Bongseong Kim, Yonghoon Choi, Cheol Min Shin, Young Soo Park, Nayoung Kim, Dong Ho Lee, Kyungdo Han, Hyuk Yoon
  Yonsei Medical Journal.2025; 66(1): 9.     CrossRef
• Temporal trends in obesity and its prognostic impact in Korean patients with inflammatory bowel disease
  Min Kyu Kim, Seung Hwan Shin, Cheol-Hyung Lee, Soyoung Kim, Jong Whan Kim, Songhyun Lee, Seung Wook Hong, Sang Hyoung Park, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Sung Wook Hwang
  Journal of Gastroenterology.2025;[Epub]     CrossRef
• Metabolic musculoskeletal disorders in patients with inflammatory bowel disease
  Young Joo Yang, Seong Ran Jeon
  The Korean Journal of Internal Medicine.2025; 40(2): 181.     CrossRef
• IFN-γ-Induced intestinal epithelial cell-type-specific programmed cell death: PANoptosis and its modulation in Crohn’s disease
  Chansu Lee, Ji Eun Kim, Yeo-Eun Cha, Ji Hwan Moon, Eun Ran Kim, Dong Kyung Chang, Young-Ho Kim, Sung Noh Hong
  Frontiers in Immunology.2025;[Epub]     CrossRef
• Impact of age at diagnosis on long‐term prognosis in patients with intestinal Behçet's disease
  Ji Young Chang, Soo Jung Park, Jae Jun Park, Tae Il Kim, Jae Hee Cheon, Jihye Park
  Journal of Gastroenterology and Hepatology.2024; 39(3): 519.     CrossRef
• Factors Associated with Reaching Mid-Parental Height in Patients Diagnosed with Inflammatory Bowel Disease in Childhood and Adolescent Period
  So Yoon Choi, Sujin Choi, Byung-Ho Choe, Jae Hong Park, Kwang-Hae Choi, Hae Jeong Lee, Ji Sook Park, Ji-Hyun Seo, Jae Young Kim, Hyo-Jeong Jang, Suk Jin Hong, Eun Young Kim, Yeoun Joo Lee, Ben Kang
  Gut and Liver.2024; 18(1): 106.     CrossRef
• Fecal Calprotectin at Postinduction Is Capable of Predicting Persistent Remission and Endoscopic Healing after 1 Year of Treatment with Infliximab in Pediatric Patients with Crohn’s Disease
  Yoo Min Lee, Eun Sil Kim, Sujin Choi, Hyo-Jeong Jang, Yu Bin Kim, So Yoon Choi, Byung-Ho Choe, Ben Kang
  Gut and Liver.2024; 18(3): 498.     CrossRef
• Safety of Biologics and Small Molecules for Inflammatory Bowel Diseases in Organ Transplant Recipients
  Ga Hee Kim, Minjun Kim, Kyuwon Kim, Jung-Bin Park, Ji Eun Baek, June Hwa Bae, Seung Wook Hong, Sung Wook Hwang, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Sang Hyoung Park
  Yonsei Medical Journal.2024; 65(5): 276.     CrossRef
• Optimal Treatment Approaches to Intestinal Behçet's Disease Complicated by Myelodysplastic Syndrome: The KASID and KSBD Multicenter Study
  Jung-Bin Park, So Jung Han, Seung Bum Lee, Dong Hyun Kim, Jae Hee Cheon, Sung Wook Hwang, Byong Duk Ye, Suk-Kyun Yang, Soo Jung Park, Sang Hyoung Park
  Yonsei Medical Journal.2024; 65(5): 265.     CrossRef
• Self-screening questionnaire for perianal fistulizing disease in patients with Crohn’s disease
  O Seong Kweon, Ben Kang, Yoo Jin Lee, Eun Soo Kim, Sung Kook Kim, Hyun Seok Lee, Yun Jin Chung, Kyeong Ok Kim, Byung Ik Jang
  The Korean Journal of Internal Medicine.2024; 39(3): 430.     CrossRef
• Best Practice for Therapeutic Drug Monitoring of Infliximab: Position Statement from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology
  Dahham Alsoud, Dirk Jan A. R. Moes, Zhigang Wang, Rani Soenen, Zohra Layegh, Murray Barclay, Tomoyuki Mizuno, Iris K. Minichmayr, Ron J. Keizer, Sebastian G. Wicha, Gertjan Wolbink, Jo Lambert, Séverine Vermeire, Annick de Vries, Konstantinos Papamichael,
  Therapeutic Drug Monitoring.2024; 46(3): 291.     CrossRef
• Development and Assessment of a Novel Ulcerative Colitis–Specific Quality of Life Questionnaire: A Prospective, Multi-Institutional Study
  Jihye Park, Hyun-Soo Zhang, Chung Mo Nam, Joo Sung Kim, Young-Ho Kim, Dong Il Park, Byong Duk Ye, Yoon Tae Jeen, Sehyun Kim, Jae Hee Cheon
  Yonsei Medical Journal.2024; 65(11): 636.     CrossRef
• Clinical Significance of Prognostic Nutrition Index in Patients with Crohn’s Disease after Primary Bowel Resection
  Hyeon Woo Bae, Yong Joon Lee, Min Young Park, Seung Yoon Yang, Yoon Dae Han, Min Soo Cho, Hyuk Hur, Kang Young Lee, Jae Hee Cheon, Joseph C. Carmichael, Byung Soh Min
  Yonsei Medical Journal.2024; 65(7): 380.     CrossRef
• Advancements in Targeted Therapies for the Management of Crohn’s Disease: A Comprehensive Review
  Peter Girgis, Tanisha LNU, Amna Ahmad, Mina Daniel, Maria Kamel, Jade L Gambill, Atika Shahzadi, Usman Khan, Anam Zara, Vagisha Sharma
  Cureus.2024;[Epub]     CrossRef
• One-year Safety and Effectiveness of Ustekinumab in Patients With Crohn’s Disease: The K-STAR Study
  Chang Kyun Lee, Won Moon, Jaeyoung Chun, Eun Soo Kim, Hyung Wook Kim, Hyuk Yoon, Hyun Soo Kim, Yoo Jin Lee, Chang Hwan Choi, Yunho Jung, Sung Chul Park, Geun Am Song, Jong Hun Lee, Eun Suk Jung, Youngdoe Kim, Su Young Jung, Jong Min Choi, Byong Duk Ye
  Inflammatory Bowel Diseases.2024;[Epub]     CrossRef
• Effectiveness of Switching to Subcutaneous Infliximab in Ulcerative Colitis Patients Experiencing Intravenous Infliximab Failure
  June Hwa Bae, Jung-Bin Park, Ji Eun Baek, Seung Wook Hong, Sang Hyoung Park, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Sung Wook Hwang
  Gut and Liver.2024; 18(4): 667.     CrossRef
• Management of Crohn’s disease in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease updated in 2023
  Jia-Feng Wu, Hsu-Heng Yen, Horng-Yuan Wang, Ting-An Chang, Chung-Hsin Chang, Chen-Wang Chang, Te-Hsin Chao, Jen-Wei Chou, Yenn-Hwei Chou, Chiao-Hsiung Chuang, Wen-Hung Hsu, Tzu-Chi Hsu, Tien-Yu Huang, Tsung-I Hung, Puo-Hsien Le, Chun-Che Lin, Chun-Chi Lin
  Intestinal Research.2024; 22(3): 250.     CrossRef
• Comparative risk of serious infections and tuberculosis in Korean patients with inflammatory bowel disease treated with non-anti-TNF biologics or anti-TNF-α agents: a nationwide population-based cohort study
  Min Jee Kim, Ye-Jee Kim, Daehyun Jeong, Seonok Kim, Seokchan Hong, Sang Hyoung Park, Kyung-Wook Jo
  Therapeutic Advances in Gastroenterology.2024;[Epub]     CrossRef
• Prevalence and risk factors for gallstone and renal stone formation in patients with intestinal Behçet’s disease
  Jaewon Song, Soo Jung Park, Jae Jun Park, Tae Il Kim, Jihye Park, Jae Hee Cheon
  The Korean Journal of Internal Medicine.2024; 39(5): 770.     CrossRef
• Comparative real-world outcomes between ustekinumab, infliximab, and adalimumab in bio-naïve and bio-experienced Crohn’s disease patients: a retrospective multicenter study
  Ji Eun Na, Yong Eun Park, Jongha Park, Tae-Oh Kim, Jong Hoon Lee, Su Bum Park, Soyoung Kim, Seung Bum Lee
  BMC Gastroenterology.2024;[Epub]     CrossRef
• Effectiveness of Early Thiopurine Use in Korean Patients With Moderate-to-Severe Ulcerative Colitis
  Hye Kyung Hyun, Ji Won Kim, Jun Lee, Yoon Tae Jeen, Tae-Oh Kim, Joo Sung Kim, Jae Jun Park, SungNoh Hong, Dong Il Park, Hyun-Soo Kim, YooJin Lee, Eun Suk Jung, Youngdoe Kim, Su Young Jung, Jae Hee Cheon
  Journal of Clinical Gastroenterology.2024;[Epub]     CrossRef
• Characteristics and Treatment Outcomes of Transition among Patients with Inflammatory Bowel Disease
  Eun Jin Yoo, Sang-Hoon Cho, Soo Jung Park, Tae Il Kim, Won Ho Kim, Jae Hee Cheon
  Yonsei Medical Journal.2023; 64(9): 541.     CrossRef
• Effectiveness and tolerability of methotrexate monotherapy in Crohn’s disease patients: a multicenter observational study
  Jihye Park, Jaeyoung Chun, Soo Jung Park, Jae Jun Park, Tae Il Kim, Hyuk Yoon, Jae Hee Cheon
  Therapeutic Advances in Gastroenterology.2023;[Epub]     CrossRef
• Combination therapy of ustekinumab and immunomodulator for inflammatory bowel disease: concerns about the different results observed between two meta‐analyses
  T Yoshihara, S Shinzaki, H Iijima, Y Tsujii, Y Hayashi, T Takehara
  Journal of Gastroenterology and Hepatology.2023; 38(5): 830.     CrossRef
• Safety of Biologic Therapy in Older Adults with Inflammatory Bowel Diseases
  Tae-Geun Gweon
  The Korean Journal of Gastroenterology.2023; 81(5): 230.     CrossRef
• Risk of all-cause and cause-specific mortality associated with immune-mediated inflammatory diseases in Korea
  Oh Chan Kwon, See Young Lee, Jaeyoung Chun, Kyungdo Han, Yuna Kim, Ryul Kim, Min-Chan Park, Jie-Hyun Kim, Young Hoon Youn, Hyojin Park
  Frontiers in Medicine.2023;[Epub]     CrossRef
• How have treatment patterns for patients with inflammatory bowel disease changed in Asian countries?
  Jihye Park
  Intestinal Research.2023; 21(3): 275.     CrossRef
• 10 years of biologic use patterns in patients with inflammatory bowel disease: treatment persistence, switching and dose intensification – a nationwide population-based study
  Hee Moon Koo, Yu Kyung Jun, Yonghoon Choi, Cheol Min Shin, Young Soo Park, Nayoung Kim, Dong Ho Lee, Young Kee Shin, Hyuk Yoon
  Therapeutic Advances in Gastroenterology.2023;[Epub]     CrossRef
• Enrichment of Activated Fibroblasts as a Potential Biomarker for a Non-Durable Response to Anti-Tumor Necrosis Factor Therapy in Patients with Crohn’s Disease
  Soo-Kyung Park, Gi-Young Lee, Sangsoo Kim, Chil-Woo Lee, Chang-Hwan Choi, Sang-Bum Kang, Tae-Oh Kim, Jaeyoung Chun, Jae-Myung Cha, Jong-Pil Im, Kwang-Sung Ahn, Seon-Young Kim, Min-Suk Kim, Chang-Kyun Lee, Dong-Il Park
  International Journal of Molecular Sciences.2023; 24(19): 14799.     CrossRef
• Evaluation of Bacterial and Fungal Biomarkers for Differentiation and Prognosis of Patients with Inflammatory Bowel Disease
  Hyuk Yoon, Sunghyouk Park, Yu Kyung Jun, Yonghoon Choi, Cheol Min Shin, Young Soo Park, Nayoung Kim, Dong Ho Lee
  Microorganisms.2023; 11(12): 2882.     CrossRef

Ulcerative colitis (UC) is a chronic inflammatory bowel disease characterized by a relapsing and remitting course. The direct and indirect costs of the treatment of UC are high, and the quality of life of patients is reduced, especially during exacerbation of the disease. The incidence and prevalence of UC in Korea are still lower than those of Western countries, but have been rapidly increasing during the past decades. Various medical and surgical therapies, including biologics, are currently used for the management of UC. However, many challenging issues exist, which sometimes lead to differences in practice between clinicians. Therefore, the IBD study group of the Korean Association for the Study of Intestinal Diseases established the first Korean guidelines for the management of UC in 2012. This is an update of the first guidelines. It was generally made by the adaptation of several foreign guidelines as was the first edition, and encompasses treatment of active colitis, maintenance of remission, and indication of surgery for UC. The specific recommendations are presented with the quality of evidence and classification of recommendations.

Citations

Citations to this article as recorded by  

• Comparison of Effects on 6-Thioguanine Nucleotides According to Mesalazine Formulation in Pediatric Patients with Ulcerative Colitis
  Hansol Kim, Yoon Zi Kim, Seon Young Kim, Yon Ho Choe, Mi Jin Kim
  Clinical Therapeutics.2025; 47(3): 196.     CrossRef
• Comparison of 1‐Year Clinical Course in Patients With Newly Diagnosed Inflammatory Bowel Disease Between Vietnam and Korea: A Multinational, Multicenter Retrospective Cohort Study
  Luan Minh Dang, Eun Soo Kim, Kyeong Ok Kim, Yoo Jin Lee, Hoang Huu Bui, Chuong Dinh Nguyen, Chi Thi Nguyen, Nam Hoai Nguyen, Hien Thi‐Thu Nguyen, Nga Thi Dinh, Lien Thi‐Phuong Nguyen, Khien Van Vu, Minh Cuong Duong
  JGH Open.2025;[Epub]     CrossRef
• The impact of gut microbiome enterotypes on ulcerative colitis: identifying key bacterial species and revealing species co-occurrence networks using machine learning
  Xuangao Wu, Ting Zhang, TianShun Zhang, Sunmin Park
  Gut Microbes.2024;[Epub]     CrossRef
• Complementary Therapeutic Effect of Fecal Microbiota Transplantation in Ulcerative Colitis after the Response to Anti-Tumor Necrosis Factor Alpha Agent Was Lost: A Case Report
  Jongbeom Shin, Ga Hyeon Baek, Boram Cha, Soo-Hyun Park, Jung-Hwan Lee, Jun-Seob Kim, Kye Sook Kwon
  Biomedicines.2024; 12(4): 800.     CrossRef
• Anti‐inflammatory and anti‐hyperalgesic effects induced by an aqueous aged black garlic extract in rodent models of ulcerative colitis and colitis‐associated visceral pain
  Maria Loreta Libero, Elena Lucarini, Lucia Recinella, Clara Ciampi, Serena Veschi, Anna Piro, Annalisa Chiavaroli, Alessandra Acquaviva, Nilofar Nilofar, Giustino Orlando, Daniele Generali, Carla Ghelardini, Lorenzo di Cesare Mannelli, Antonio J. Montero‐
  Phytotherapy Research.2024; 38(8): 4177.     CrossRef
• Risks of Cancer Associated with Therapeutic Drugs for Inflammatory Bowel Disease
  Won Moon, Jae Jun Park
  The Korean Journal of Gastroenterology.2024; 83(6): 233.     CrossRef
• Old and New Biologics and Small Molecules in Inflammatory Bowel Disease: Anti-Tumor Necrosis Factors
  Sang Un Kim, Hyun Seok Lee
  The Korean Journal of Gastroenterology.2024; 84(2): 35.     CrossRef
• Inflammatory Bowel Disease: Pathophysiology, Treatment, and Disease Modeling
  Jiryeon Jang, Sehoon Jeong
  BioChip Journal.2023; 17(4): 403.     CrossRef
• Factors associated with the prescription of probiotics in patients with inflammatory bowel disease: a cross-sectional study
  Joo Kyung Kim, Jae Hee Cheon
  Journal of Yeungnam Medical Science.2023; 40(1): 37.     CrossRef
• Korean clinical practice guidelines on biologics and small molecules for moderate-to-severe ulcerative colitis
  Soo-Young Na, Chang Hwan Choi, Eun Mi Song, Ki Bae Bang, Sang Hyoung Park, Eun Soo Kim, Jae Jun Park, Bora Keum, Chang Kyun Lee, Bo-In Lee, Seung-Bum Ryoo, Seong-Joon Koh, Miyoung Choi, Joo Sung Kim
  Intestinal Research.2023; 21(1): 61.     CrossRef
• Real-life effectiveness and safety of tofacitinib treatment in patients with ulcerative colitis: a KASID multicenter cohort study
  Seung Hwan Shin, Kyunghwan Oh, Sung Noh Hong, Jungbok Lee, Shin Ju Oh, Eun Soo Kim, Soo-Young Na, Sang-Bum Kang, Seong-Joon Koh, Ki Bae Bang, Sung-Ae Jung, Sung Hoon Jung, Kyeong Ok Kim, Sang Hyoung Park, Suk-Kyun Yang, Chang Hwan Choi, Byong Duk Ye
  Therapeutic Advances in Gastroenterology.2023;[Epub]     CrossRef
• Low Serum Hepcidin Levels in Patients with Ulcerative Colitis – Implications for Treatment of Co-existent Iron-Deficiency Anemia
  Jagadish Ramasamy, Chinmai Jagadish, Abitha Sukumaran, Joe Varghese, Thenmozhi Mani, A. J. Joseph, Ebby George Simon, Molly Jacob
  Inflammation.2023; 46(6): 2209.     CrossRef
• Screening for Chemical Characterization and Pharmacological Properties of Different Extracts from Nepeta italica
  Alessandra Acquaviva, Simonetta Cristina Di Simone, Nilofar, Abdelhakim Bouyahya, Gokhan Zengin, Lucia Recinella, Sheila Leone, Luigi Brunetti, Abdullahi Ibrahim Uba, Osman Guler, Maruf Balos, Ugur Cakilcioğlu, Luigi Menghini, Claudio Ferrante, Giustino
  Plants.2023; 12(15): 2785.     CrossRef
• Treatment of inflammatory bowel disease–Asian perspectives: the results of a multinational web-based survey in the 8th Asian Organization for Crohn’s and Colitis meeting
  Eun Mi Song, Soo-Young Na, Sung Noh Hong, Siew Chien Ng, Tadakazu Hisamatsu, Byong Duk Ye
  Intestinal Research.2023; 21(3): 339.     CrossRef
• Infectious complications in patients with inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 8th Asian Organization for Crohn’s and Colitis meeting
  Yu Kyung Jun, Seong-Joon Koh, Dae Seong Myung, Sang Hyoung Park, Choon Jin Ooi, Ajit Sood, Jong Pil Im
  Intestinal Research.2023; 21(3): 353.     CrossRef
• Advancements in the Management of Moderate-to-Severe Ulcerative Colitis: A Revised 2023 Korean Treatment Guidelines
  Soo-Young Na
  The Korean Journal of Medicine.2023; 98(5): 223.     CrossRef
• Comparison of 1-Year Colectomy Risk Between the US and Korean Patients with Acute Severe Ulcerative Colitis: A Propensity Score Matching Analysis
  Eun Soo Kim, Kyeong Ok Kim, Byung Ik Jang, Eun Young Kim, Yoo Jin Lee, Hyun Seok Lee, Joon Seop Lee, Sung Kook Kim, Yun Jin Jung, Sang-Bum Kang, Manasi Agrawal, Ryan Ungaro, Jean-Frederic Colombel
  Digestive Diseases and Sciences.2022; 67(7): 2866.     CrossRef
• Cytomegalovirus in ulcerative colitis: an evidence-based approach to diagnosis and treatment
  Anuraag Jena, Shubhra Mishra, Anupam Kumar Singh, Aravind Sekar, Vishal Sharma
  Expert Review of Gastroenterology & Hepatology.2022; 16(2): 109.     CrossRef
• Efficacy of sigmoidoscopy for evaluating disease activity in patients with ulcerative colitis
  Su Bum Park, Seong-Jung Kim, Jun Lee, Yoo Jin Lee, Dong Hoon Baek, Geom Seog Seo, Eun Soo Kim, Sang-Wook Kim, So Yeong Kim
  BMC Gastroenterology.2022;[Epub]     CrossRef
• Identification of useful genes from multiple microarrays for ulcerative colitis diagnosis based on machine learning methods
  Lin Zhang, Rui Mao, Chung Tai Lau, Wai Chak Chung, Jacky C. P. Chan, Feng Liang, Chenchen Zhao, Xuan Zhang, Zhaoxiang Bian
  Scientific Reports.2022;[Epub]     CrossRef
• Oral beclomethasone dipropionate as an add-on therapy and response prediction in Korean patients with ulcerative colitis
  Kyuwon Kim, Hee Seung Hong, Kyunghwan Oh, Jae Yong Lee, Seung Wook Hong, Jin Hwa Park, Sung Wook Hwang, Dong-Hoon Yang, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Byong Duk Ye, Sang Hyoung Park
  The Korean Journal of Internal Medicine.2022; 37(6): 1140.     CrossRef
• Additive effect of probiotics (Mutaflor) on 5-aminosalicylic acid therapy in patients with ulcerative colitis
  Soo-Kyung Park, Sang-Bum Kang, SangSoo Kim, Tae Oh Kim, Jae Myung Cha, Jong Pil Im, Chang Hwan Choi, Eun Soo Kim, Geom Seog Seo, Chang Soo Eun, Dong Soo Han, Dong Il Park
  The Korean Journal of Internal Medicine.2022; 37(5): 949.     CrossRef
• Physician education can minimize inappropriate steroid use in patients with inflammatory bowel disease: the ACTION study
  Yehyun Park, Chang Hwan Choi, Hyun Soo Kim, Hee Seok Moon, Do Hyun Kim, Jin Ju Kim, Dennis Teng, Dong Il Park
  Intestinal Research.2022; 20(4): 452.     CrossRef
• Corticosteroid, a double-edged sword in inflammatory bowel disease management: possibility of reducing corticosteroid use through physician education
  Seulji Kim, Seong-Joon Koh
  Intestinal Research.2022; 20(4): 389.     CrossRef
• La escala control nutricional (CONUT): una herramienta prometedora para el cribado nutricional y como predictor de severidad en la colitis ulcerosa crónica idiopática
  J.L. de-León-Rendón, R.Y. López-Pérez, N.I. Gracida-Mancilla, B. Jiménez-Bobadilla, L. Alarcón-Bernés, S. Mendoza-Ramírez, J.A. Villanueva-Herrero
  Revista de Gastroenterología de México.2021; 86(2): 110.     CrossRef
• Advances in Management of Intestinal Behçet’s Disease: A Perspective From Gastroenterologists
  Jae Hee Cheon
  Journal of Rheumatic Diseases.2021; 28(1): 4.     CrossRef
• Tumor Necrosis Factor-Alpha Inhibitor-Associated Psoriatic Alopecia in a Patient with Ulcerative Colitis: A Case Report and Review of the Literature
  Kyung Muk Jeong, Ji Yun Seo, Anna Kim, Yoo Sang Baek, Hae Jun Song, Jiehyun Jeon
  Annals of Dermatology.2021; 33(1): 82.     CrossRef
• The role of platelet to lymphocyte ratio and neutrophil to lymphocyte ratio in ulcerative colitis
  Yujin Jeong, Seong Ran Jeon, Hyun Gun Kim, Jung Rock Moon, Tae Hee Lee, Jae Young Jang, Jun-Hyung Cho, Jun Seok Park, Heesu Park, Ki-hun Lee, Jin-Oh Kim, Joon Seong Lee, Bong Min Ko, Suyeon Park
  Intestinal Research.2021; 19(1): 62.     CrossRef
• Comparative Study of Anti-Inflammatory Effect on DSS-Induced Ulcerative Colitis Between Novel Glycyrrhiza Variety and Official Compendia
  Sa-Haeng Kang, Young-Jae Song, Yong-Deok Jeon, Dong-Keun Kim, Jeong-Hyang Park, Ju-Ryoun Soh, Jong-Hyun Lee, Christopher Kitalong, Wonnam Kim, Hyo-Jin An, Jae-Ki Chang, Jeonghoon Lee, Jong-Sik Jin
  Applied Sciences.2021; 11(4): 1545.     CrossRef
• McN-A-343, a muscarinic agonist, reduces inflammation and oxidative stress in an experimental model of ulcerative colitis
  Diva de Aguiar Magalhães, Jalles Arruda Batista, Stefany Guimarães Sousa, Jayro dos Santos Ferreira, Lauanda da Rocha Rodrigues, Cynthia Maria Carvalho Pereira, José Victor do Nascimento Lima, Ieda Figueira de Albuquerque, Nayonara Lanara Sousa Dutra Beze
  Life Sciences.2021; 272: 119194.     CrossRef
• Comparison of Long-Term Outcomes of Infliximab versus Adalimumab Treatment in Biologic-Naïve Patients with Ulcerative Colitis
  Yong Il Lee, Yehyun Park, Soo Jung Park, Tae Il Kim, Won Ho Kim, Jae Hee Cheon
  Gut and Liver.2021; 15(2): 232.     CrossRef
• The controlling nutritional status score: A promising tool for nutritional screening and predicting severity in ulcerative colitis patients
  J.L. de-León-Rendón, R.Y. López-Pérez, N.I. Gracida-Mancilla, B. Jiménez-Bobadilla, L. Alarcón-Bernés, S. Mendoza-Ramírez, J.A. Villanueva-Herrero
  Revista de Gastroenterología de México (English Edition).2021; 86(2): 110.     CrossRef
• Comparison of outcomes of cyclosporine A and infliximab for steroid‐refractory acute severe ulcerative colitis
  Eun Mi Song, Eun Hye Oh, Sung Wook Hwang, Sang Hyoung Park, Dong‐Hoon Yang, Jeong‐Sik Byeon, Seung‐Jae Myung, Suk‐Kyun Yang, Byong Duk Ye
  Journal of Gastroenterology and Hepatology.2021; 36(9): 2463.     CrossRef
• Clinical Significance of Residual Nonrectal Inflammation in Ulcerative Colitis Patients in Clinical Remission
  Jongbeom Shin, Sung Min Kong, Tae Jun Kim, Eun Ran Kim, Sung Noh Hong, Dong Kyung Chang, Young-Ho Kim
  Gut and Liver.2021; 15(3): 401.     CrossRef
• The real-world outcomes of vedolizumab in patients with ulcerative colitis in Korea: a multicenter retrospective study
  Byong Duk Ye, Jae Hee Cheon, Ki Hwan Song, Joo Sung Kim, Young-Ho Kim, Hyuk Yoon, Kang-Moon Lee, Sang-Bum Kang, Byung Ik Jang, Jae Jun Park, Tae Oh Kim, Dae-Wook Lee, Chee Yoong Foo, Jeong Eun Shin, Dong Il Park
  Therapeutic Advances in Gastroenterology.2021;[Epub]     CrossRef
• Efficacy and safety of Etiasa for treatment of mild-to-moderate ulcerative colitis: A Meta-analysis
  Fang-Mei Ling, Fei-Nan Lu, Sheng-Nan Wang, Liang-Ru Zhu
  World Chinese Journal of Digestology.2021; 29(15): 880.     CrossRef
• Draft Genome Sequence of Paraclostridium bifermentans subsp. muricolitidis Strain PAGU 1678 T , Which Exacerbates Pathosis in a Mouse Model of Ulcerative Colitis
  Ryo Kutsuna, Tohru Miyoshi-Akiyama, Junko Tomida, Yoshiaki Kawamura, Steven R. Gill
  Microbiology Resource Announcements.2021;[Epub]     CrossRef
• Treatment of inflammatory bowel diseases: focusing on 5-aminosalicylates and immunomodulators
  You Sun Kim
  Journal of the Korean Medical Association.2021; 64(9): 596.     CrossRef
• Is fasting beneficial for hospitalized patients with inflammatory bowel diseases?
  Yong Eun Park, Yehyun Park, Soo Jung Park, Tae Il Kim, Won Ho Kim, Jung Nam Kim, Na Rae Lee, Jae Hee Cheon
  Intestinal Research.2020; 18(1): 85.     CrossRef
• Biologic Use Patterns and Predictors for Non-persistence and Switching of Biologics in Patients with Inflammatory Bowel Disease: A Nationwide Population-Based Study
  Yoon Suk Jung, Minkyung Han, Sohee Park, Jae Hee Cheon
  Digestive Diseases and Sciences.2020; 65(5): 1436.     CrossRef
• Fecal calprotectin is more accurate than fecal immunochemical test for predicting mucosal healing in quiescent ulcerative colitis: a prospective multicenter study
  Eun Soo Kim, Hyun Seok Lee, Sung Kook Kim, Eun Young Kim, Byung Ik Jang, Kyeong Ok Kim, Chang Heon Yang, Yoo Jin Lee
  Scandinavian Journal of Gastroenterology.2020; 55(2): 163.     CrossRef
• Multidirectional Pharma-Toxicological Study on Harpagophytum procumbens DC. ex Meisn.: An IBD-Focused Investigation
  Lucia Recinella, Annalisa Chiavaroli, Maurizio Ronci, Luigi Menghini, Luigi Brunetti, Sheila Leone, Bruno Tirillini, Paola Angelini, Stefano Covino, Roberto Venanzoni, Gokhan Zengin, Simonetta Di Simone, Maria Chiara Ciferri, Viviana di Giacomo, Amelia Ca
  Antioxidants.2020; 9(2): 168.     CrossRef
• Pregnancy outcomes in women with inflammatory bowel disease: a 10‐year nationwide population‐based cohort study
  Han H. Lee, Jung Min Bae, Bo‐In Lee, Kang‐Moon Lee, Jeong H. Wie, Jin S. Kim, Young‐Seok Cho, Sung‐Ae Jung, Sang W. Kim, Hwang Choi, Myung‐Gyu Choi
  Alimentary Pharmacology & Therapeutics.2020; 51(9): 861.     CrossRef
• Effect of Age on the Initiation of Biologic Agent Therapy in Patients With Inflammatory Bowel Disease: Korean Common Data Model Cohort Study
  Youn I Choi, Yoon Jae Kim, Jun-Won Chung, Kyoung Oh Kim, Hakki Kim, Rae Woong Park, Dong Kyun Park
  JMIR Medical Informatics.2020; 8(4): e15124.     CrossRef
• Mechanism-based Drug Therapy of Inflammatory Bowel Disease With Special Reference to Rheumatic Disease
  Jae Jun Park
  Journal of Rheumatic Diseases.2020; 27(3): 128.     CrossRef
• Sarcopenia Is a New Risk Factor of Nonalcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Disease
  Min Kyu Kang, Kyeong Ok Kim, Min Cheol Kim, Jung Gil Park, Byung Ik Jang
  Digestive Diseases.2020; 38(6): 507.     CrossRef
• Regional variations in the use of biologics and immunomodulators among Korean patients with inflammatory bowel diseases
  Minkyung Han, Yoon Suk Jung, Jae Hee Cheon, Sohee Park
  Journal of Gastroenterology and Hepatology.2019; 34(7): 1166.     CrossRef
• Adherence to Asacol once daily versus divided regimen for maintenance therapy in ulcerative colitis: a prospective, multicenter, randomized study
  Soo-Kyung Park, Sang Hyun Park, Chang Soo Eun, Geom Seog Seo, Jong Pil Im, Tae Oh Kim, Dong-Il Park
  Intestinal Research.2019; 17(3): 349.     CrossRef
• Two-year delay in ulcerative colitis diagnosis is associated with anti-tumor necrosis factor alpha use
  Ho Suk Kang, Ja-Seol Koo, Kang Moon Lee, Dae-Bum Kim, Ji Min Lee, Yoon Jae Kim, Hyuk Yoon, Hyun Joo Jang
  World Journal of Gastroenterology.2019; 25(8): 989.     CrossRef
• A Real-World Analysis of Prescribing Patterns and Non-persistence of Anti-TNFα Therapy for Inflammatory Bowel Disease
  Eun Jin Jang, Jung Eun Ha, Seul Gi Im, Myeong Gyu Kim, Hyun Soon Sohn
  Clinical Drug Investigation.2019; 39(7): 625.     CrossRef
• Medication Use and Drug Expenditure in Inflammatory Bowel Disease: based on Korean National Health Insurance Claims Data (2010-2014)
  Jung Eun Ha, Eun Jin Jang, Seul Gi Im, Hyun Soon Sohn
  Korean Journal of Clinical Pharmacy.2019; 29(2): 79.     CrossRef
• Protective effects induced by alcoholic Phlomis fruticosa and Phlomis herba‐venti extracts in isolated rat colon: Focus on antioxidant, anti‐inflammatory, and antimicrobial activities in vitro
  Claudio Ferrante, Lucia Recinella, Maurizio Ronci, Giustino Orlando, Simonetta Di Simone, Luigi Brunetti, Annalisa Chiavaroli, Sheila Leone, Matteo Politi, Bruno Tirillini, Paola Angelini, Stefano Covino, Roberto Venanzoni, Sanda Vladimir‐Knežević, Luigi
  Phytotherapy Research.2019; 33(9): 2387.     CrossRef
• Current Evidence for the Management of Inflammatory Bowel Diseases Using Fecal Microbiota Transplantation
  Seong Ran Jeon, Jocelyn Chai, Christiana Kim, Christine H. Lee
  Current Infectious Disease Reports.2018;[Epub]     CrossRef
• Monitoring Disease Activity: How and When?
  Kang-Moon Lee
  The Korean Journal of Gastroenterology.2018; 71(2): 69.     CrossRef
• Novel treatments for inflammatory bowel disease
  Hyo Sun Lee, Soo-Kyung Park, Dong Il Park
  The Korean Journal of Internal Medicine.2018; 33(1): 20.     CrossRef
• How to Optimally Use Currently Available Drugs in a Therapeutic Algorithm?
  You Sun Kim
  The Korean Journal of Gastroenterology.2018; 71(2): 74.     CrossRef
• Endoscopic Transplantation of Mesenchymal Stem Cell Sheets in Experimental Colitis in Rats
  Sehyung Pak, Sung Wook Hwang, In Kyong Shim, Sang Mun Bae, Yeon- Mi Ryu, Han-Byul Kim, Eun-ju Do, Hye-Nam Son, Eun-ji Choi, Sun-ha Park, Sang-Yeob Kim, Sang Hyoung Park, Byong Duk Ye, Suk-Kyun Yang, Nobuo Kanai, Masanori Maeda, Teruo Okano, Dong-Hoon Yang
  Scientific Reports.2018;[Epub]     CrossRef
• Is once daily multimatrix mesalazine therapy effective regardless of the dose in patients with mild to moderate ulcerative colitis?
  Seong Ran Jeon
  Intestinal Research.2018; 16(2): 163.     CrossRef
• Is Clostridium difficile infection a real threat in patients with ulcerative colitis? A prospective, multicenter study in Korea
  Dae Bum Kim, Kang-Moon Lee, Sang Hyoung Park, You Sun Kim, Eun Soo Kim, Jun Lee, Sung-Ae Jung, Geom Seog Seo, Ji Min Lee
  Intestinal Research.2018; 16(2): 267.     CrossRef
• Mesenchymal Stromal Cells in the Treatment of Perianal Fistulas in Crohn'S Disease
  Jesús Castro-Poceiro, Agnès Fernández-Clotet, Julián Panés
  Immunotherapy.2018; 10(14): 1203.     CrossRef
• Efficacy and Safety of UI05MSP015CT in Functional Dyspepsia: A Randomized, Controlled Trial
  Hyuk Yoon, Dong Ho Lee, Yong-Hyun Lee, Ju-Cheol Jeong, Soo Teik Lee, Myung-Gyu Choi, Seong Woo Jeon, Ki-Nam Shim, Gwang Ho Baik, Jae Gyu Kim, Jeong Seop Moon, In-Kyung Sung, Sang Kil Lee, Poong-Lyul Rhee, Hwoon-Yong Jung, Bong Eun Lee, Hyun Soo Kim, Sang
  Gut and Liver.2018; 12(5): 516.     CrossRef
• Could adalimumab be used safely and effectively in intestinal Behçet's disease refractory to conventional therapy?
  Jihye Park, Jae Hee Cheon
  Intestinal Research.2017; 15(3): 263.     CrossRef
• Fatal infections in older patients with inflammatory bowel disease on anti-tumor necrosis factor therapy
  Way-Seah Lee, Najib Azmi, Ruey-Terng Ng, Sik-Yong Ong, Sasheela Sri La Ponnampalavanar, Sanjiv Mahadeva, Ida Hilmi
  Intestinal Research.2017; 15(4): 524.     CrossRef

Citations

Citations to this article as recorded by  

• Diagnosis change in pediatric inflammatory bowel disease
  Harold Duarte, Adrienne Stolfi, Courtney McCall, Shehzad Saeed, Kelly Sandberg
  Journal of Pediatric Gastroenterology and Nutrition.2024; 78(3): 623.     CrossRef
• A Case Report and Literature Review of Rectosigmoid Crohn’s Disease: A Diagnostic Pitfall Ultimately Leading to Spontaneous Colonic Perforation
  Muhammad Z Ali, Muhammad Usman Tariq, Muhammad Hasan Abid, Hamma Abdulaziz, Mohmmad AlAdwani, Arif Khurshid, Muhammad Rashid, Fawaz Al Thobaiti , Amjad Althagafi
  Cureus.2023;[Epub]     CrossRef
• Efficacy of vedolizumab as maintenance therapy in a patient with ulcerative colitis receiving haemodialysis in end-stage kidney failure: A case report
  Guglielmo Albertini Petroni, Laura Francesca Pisani, Edoardo Borsotti, Maria Doria, Maria Laura Annunziata
  SAGE Open Medical Case Reports.2023;[Epub]     CrossRef
• Thirty-year Trend in Inflammatory Bowel Disease on Jeju Island, South Korea
  Jin Woo Kim, Hyun Joo Song, Sun-Jin Boo, Heung Up Kim, Ki Soo Kang, Soo-Young Na
  The Korean Journal of Gastroenterology.2023; 81(6): 243.     CrossRef
• PD-1-positive cells contribute to the diagnosis of inflammatory bowel disease and can aid in predicting response to vedolizumab
  Min Kyu Kim, Su In Jo, Sang-Yeob Kim, Hyun Lim, Ho Suk Kang, Sung‑Hoon Moon, Byong Duk Ye, Jae Seung Soh, Sung Wook Hwang
  Scientific Reports.2023;[Epub]     CrossRef
• IBD barriers across the continents – East Asia
  Joyce Wing Yan Mak, Agnes Hiu Yan Ho, Siew Chien Ng
  Therapeutic Advances in Gastroenterology.2023;[Epub]     CrossRef
• Inflammatory bowel disease in Korea: epidemiology and pathophysiology
  Jung Won Lee, Chang Soo Eun
  The Korean Journal of Internal Medicine.2022; 37(5): 885.     CrossRef
• Systematic evaluation of the diagnostic approach of inflammatory bowel disease guidelines
  Bing‐He Xiao, Xu‐Dong Ma, Jia‐Jun Lv, Ting Yang, Xin‐Jie Liu, Li‐Ya An, Yu‐Xing Qi, Ming‐Liang Lu, Yong‐Qing Duan, Da‐Li Sun
  International Journal of Clinical Practice.2021;[Epub]     CrossRef
• Clinical characteristics and prognosis of patients with ulcerative colitis that shows rectal sparing at initial diagnosis
  Yong-Sung Choi, Jong-Kyu Kim, Wan-Jung Kim
  World Journal of Gastrointestinal Endoscopy.2021; 13(9): 407.     CrossRef
• Current status of inflammatory bowel diseases in Korea
  Suk-Kyun Yang
  Journal of the Korean Medical Association.2021; 64(9): 572.     CrossRef
• EpidemIBD: rationale and design of a large-scale epidemiological study of inflammatory bowel disease in Spain
  María Chaparro, Manuel Barreiro-de Acosta, José Manuel Benítez, José Luis Cabriada, María José Casanova, Daniel Ceballos, María Esteve, Hipólito Fernández, Daniel Ginard, Fernando Gomollón, Rufo Lorente, Pilar Nos, Sabino Riestra, Montserrat Rivero, Pilar
  Therapeutic Advances in Gastroenterology.2019;[Epub]     CrossRef
• Illuminating an Invisible Epidemic: A Systemic Review of the Clinical and Economic Benefits of Early Diagnosis and Treatment in Inflammatory Disease and Related Syndromes
  Lukasz S. Wylezinski, Jamieson D. Gray, Julia B. Polk, Andrew J. Harmata, Charles F. Spurlock
  Journal of Clinical Medicine.2019; 8(4): 493.     CrossRef
• Impact of Cumulative Corticosteroid Dosage on Preventable Hospitalization among Taiwanese Patients with Ankylosing Spondylitis and Inflammatory Bowel Disease
  Beth I. Wallace, Chelsea A. Harris, Lu Wang, Mochuan Liu, Jung-Sheng Chen, Chang-Fu Kuo, Kevin C. Chung
  Journal of Clinical Medicine.2019; 8(5): 614.     CrossRef
• Perforated diverticulitis in the setting of ulcerative colitis: An unusual case report
  M. Baimas-George, L. Cetrulo, A. Kao, K.R. Kasten
  International Journal of Surgery Case Reports.2018; 49: 126.     CrossRef
• Assessment of factors associated with smoking cessation at diagnosis or during follow‐up of Crohn's disease
  Eun Mi Song, Gwang‐Un Kim, Myeongsook Seo, Sung Wook Hwang, Sang Hyoung Park, Eunja Kwon, Ho‐Su Lee, Dong‐Hoon Yang, Kyung‐Jo Kim, Byong Duk Ye, Jeong‐Sik Byeon, Seung‐Jae Myung, Suk‐Kyun Yang
  Journal of Gastroenterology and Hepatology.2018; 33(1): 180.     CrossRef
• Incidence and Clinical Outcomes of Inflammatory Bowel Disease in South Korea, 2011–2014: A Nationwide Population-Based Study
  Yoon Suk Jung, Minkyung Han, Won Ho Kim, Sohee Park, Jae Hee Cheon
  Digestive Diseases and Sciences.2017; 62(8): 2102.     CrossRef
• Human alpha defensin 5 is a candidate biomarker to delineate inflammatory bowel disease
  Amanda D. Williams, Olga Y. Korolkova, Amos M. Sakwe, Timothy M. Geiger, Samuel D. James, Roberta L. Muldoon, Alan J. Herline, J. Shawn Goodwin, Michael G. Izban, Mary K. Washington, Duane T. Smoot, Billy R. Ballard, Maria Gazouli, Amosy E. M'Koma, Shree
  PLOS ONE.2017; 12(8): e0179710.     CrossRef
• Clinical course of ulcerative colitis patients who develop acute pancreatitis
  Jong Wook Kim, Sung Wook Hwang, Sang Hyoung Park, Tae Jun Song, Myung-Hwan Kim, Ho-Su Lee, Byong Duk Ye, Dong-Hoon Yang, Kyung-Jo Kim, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang
  World Journal of Gastroenterology.2017; 23(19): 3505.     CrossRef
• Overall and cause‐specific mortality in Korean patients with inflammatory bowel disease: A hospital‐based cohort study
  Ho‐Su Lee, Jaewon Choe, Seon‐Ok Kim, Sun‐Ho Lee, Hyo Jeong Lee, Hyungil Seo, Gwang‐Un Kim, Myeongsook Seo, Eun Mi Song, Sung Wook Hwang, Sang Hyoung Park, Dong‐Hoon Yang, Kyung‐Jo Kim, Byong Duk Ye, Jeong‐Sik Byeon, Seung‐Jae Myung, Yong Sik Yoon, Chang S
  Journal of Gastroenterology and Hepatology.2017; 32(4): 782.     CrossRef
• Endoscopic Diagnosis and Differentiation of Inflammatory Bowel Disease
  Ji Min Lee, Kang-Moon Lee
  Clinical Endoscopy.2016; 49(4): 370.     CrossRef

Citations

Citations to this article as recorded by  

• A Case of Duodenal Ganglioneuroma Manifesting as a Subepithelial Tumor
  Dong Chan Joo, Gwang Ha Kim, Chul Byung Chae, So Jeong Lee, Do Youn Park
  The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2018; 18(4): 271.     CrossRef